These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 30515210)
1. Intranasal Insulin Administration Does Not Affect LH Concentrations in Men with Diabetes. Dhindsa S; Chemitiganti R; Ghanim H; Santiago E; Haider A; Chaar N; Mok M; McKee A; Dandona P Int J Endocrinol; 2018; 2018():6170154. PubMed ID: 30515210 [TBL] [Abstract][Full Text] [Related]
2. Fasting suppresses pulsatile luteinizing hormone (LH) secretion and enhances orderliness of LH release in young but not older men. Bergendahl M; Aloi JA; Iranmanesh A; Mulligan TM; Veldhuis JD J Clin Endocrinol Metab; 1998 Jun; 83(6):1967-75. PubMed ID: 9626127 [TBL] [Abstract][Full Text] [Related]
3. Effects of Intranasal Insulin on Triglyceride-Rich Lipoprotein Particle Production in Healthy Men. Xiao C; Dash S; Stahel P; Lewis GF Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1776-1781. PubMed ID: 28751575 [TBL] [Abstract][Full Text] [Related]
4. Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. van den Berghe G; Weekers F; Baxter RC; Wouters P; Iranmanesh A; Bouillon R; Veldhuis JD J Clin Endocrinol Metab; 2001 Jul; 86(7):3217-26. PubMed ID: 11443192 [TBL] [Abstract][Full Text] [Related]
5. Poorly controlled type I diabetes mellitus in young men selectively suppresses luteinizing hormone secretory burst mass. López-Alvarenga JC; Zariñán T; Olivares A; González-Barranco J; Veldhuis JD; Ulloa-Aguirre A J Clin Endocrinol Metab; 2002 Dec; 87(12):5507-15. PubMed ID: 12466346 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the hypothalamic-pituitary-gonadal axis in eugonadal men with type 2 diabetes mellitus. Costanzo PR; Suárez SM; Scaglia HE; Zylbersztein C; Litwak LE; Knoblovits P Andrology; 2014 Jan; 2(1):117-24. PubMed ID: 24282162 [TBL] [Abstract][Full Text] [Related]
7. Contrasts in the gonadotropin-releasing hormone dose-response relationships for luteinizing hormone, follicle-stimulating hormone and alpha-subunit release in young versus older men: appraisal with high-specificity immunoradiometric assay and deconvolution analysis. Zwart AD; Urban RJ; Odell WD; Veldhuis JD Eur J Endocrinol; 1996 Oct; 135(4):399-406. PubMed ID: 8921820 [TBL] [Abstract][Full Text] [Related]
8. Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes. Dhindsa S; Ghanim H; Batra M; Kuhadiya ND; Abuaysheh S; Sandhu S; Green K; Makdissi A; Hejna J; Chaudhuri A; Punyanitya M; Dandona P Diabetes Care; 2016 Jan; 39(1):82-91. PubMed ID: 26622051 [TBL] [Abstract][Full Text] [Related]
10. Pulsatile intravenous gonadotropin-releasing hormone administration averts fasting-induced hypogonadotropism and hypoandrogenemia in healthy, normal weight men. Aloi JA; Bergendahl M; Iranmanesh A; Veldhuis JD J Clin Endocrinol Metab; 1997 May; 82(5):1543-8. PubMed ID: 9141547 [TBL] [Abstract][Full Text] [Related]
11. An assessment of the central disposition of intranasally administered insulin lispro in the cerebrospinal fluid of healthy volunteers and beagle dogs. Lowe S; Sher E; Wishart G; Jackson K; Yuen E; Brittain C; Fong SC; Clarke DO; Landschulz WH Drug Deliv Transl Res; 2017 Feb; 7(1):11-15. PubMed ID: 27553192 [TBL] [Abstract][Full Text] [Related]
12. Intranasal insulin attenuates the hypothalamic-pituitary-adrenal axis response to psychosocial stress. Bohringer A; Schwabe L; Richter S; Schachinger H Psychoneuroendocrinology; 2008 Nov; 33(10):1394-400. PubMed ID: 18804330 [TBL] [Abstract][Full Text] [Related]
13. Tiotropium bromide. A review of its use as maintenance therapy in patients with COPD. Keam SJ; Keating GM Treat Respir Med; 2004; 3(4):247-68. PubMed ID: 15350163 [TBL] [Abstract][Full Text] [Related]
14. Age attenuates testosterone secretion driven by amplitude-varying pulses of recombinant human luteinizing hormone during acute gonadotrope inhibition in healthy men. Takahashi PY; Votruba P; Abu-Rub M; Mielke K; Veldhuis JD J Clin Endocrinol Metab; 2007 Sep; 92(9):3626-32. PubMed ID: 17579202 [TBL] [Abstract][Full Text] [Related]
15. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women. Khorram O; Laughlin GA; Yen SS J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536 [TBL] [Abstract][Full Text] [Related]
16. Effects of long-term erythropoietin therapy on the hypothalamo-pituitary-testicular axis in male CAPD patients. Tokgöz B; Utaş C; Dogukan A; Güven M; Taşkapan H; Oymak O; Keleştimur F Perit Dial Int; 2001; 21(5):448-54. PubMed ID: 11757827 [TBL] [Abstract][Full Text] [Related]
17. Unexpected inhibitory action of N-methyl-D,L-aspartate or luteinizing hormone release in adult ovariectomized rhesus monkeys: a role of the hypothalamic-adrenal axis. Reyes A; Luckhaus J; Ferin M Endocrinology; 1990 Aug; 127(2):724-9. PubMed ID: 2197080 [TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone agonist analog (nafarelin): a useful diagnostic agent for the distinction of constitutional growth delay from hypogonadotropic hypogonadism. Kletter GB; Rolfes-Curl A; Goodpasture JC; Solish SB; Scott L; Henzl MR; Beitins IZ J Pediatr Endocrinol Metab; 1996; 9(1):9-19. PubMed ID: 8887129 [TBL] [Abstract][Full Text] [Related]
19. Central nervous system effects of intranasally administered insulin during euglycemia in men. Kern W; Born J; Schreiber H; Fehm HL Diabetes; 1999 Mar; 48(3):557-63. PubMed ID: 10078556 [TBL] [Abstract][Full Text] [Related]
20. Serum leptin concentrations, luteinizing hormone and growth hormone secretion during feed and metabolic fuel restriction in the prepuberal gilt. Barb CR; Barrett JB; Kraeling RR; Rampacek GB Domest Anim Endocrinol; 2001 Jan; 20(1):47-63. PubMed ID: 11164333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]